Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06862154Phase 4Completed
A Phase 4 trial of bupivacaine hydrochloride 0.75% injection in hip fracture, sponsored by Marmara University. Started Nov 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06862154.